MYRIAD GENETICS INC (MYGN) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Myriad Genetics Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Myriad Genetics Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$656M, a 55.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$656M -$235M -55.7% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$630M -$263M -71.9% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$598M -$274M -84.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$537M -$248M -85.9% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$421M -$146M -53.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$366M -$112M -44.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$324M -$77.3M -31.3% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$289M -$17.6M -6.49% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 -$275M -$8.2M -3.08% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 -$254M -$27.2M -12% Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$247M -$57.5M -30.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$271M -$97.3M -56% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 -$267M -$148M -125% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$227M -$224M -6779% Dec 31, 2020 10-K 2022-02-25
Q3 2020 -$189M -$194M -3882% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$174M -$200M -779% Jun 30, 2020 10-KT 2021-03-16
Q1 2020 -$119M -$148M -498% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$3.3M -$26.2M -114% Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $5M -$48.4M -90.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $25.6M -$28.5M -52.7% Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $29.8M -$26.4M -47% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $22.9M -$21.9M -48.9% Dec 31, 2018 10-Q 2019-02-06
Q3 2018 $53.4M +$40.6M +317% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $54.1M +$133M Jun 30, 2018 10-K 2019-08-13
Q1 2018 $56.2M +$138M Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $44.8M +$131M Dec 31, 2017 10-Q 2018-02-07
Q3 2017 $12.8M +$99.3M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$79.2M -$6M -8.2% Jun 30, 2017 10-K 2019-08-13
Q1 2017 -$81.4M -$12.2M -17.6% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 -$85.7M -$17.1M -24.9% Dec 31, 2016 10-Q 2017-02-08
Q3 2016 -$86.5M -$7.7M -9.77% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 -$73.2M +$3.8M +4.94% Jun 30, 2016 10-K 2017-08-09
Q1 2016 -$69.2M -$6.92M -11.1% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 -$68.6M -$31.6M -85.5% Dec 31, 2015 10-Q 2016-02-03
Q3 2015 -$78.8M -$61.4M -352% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 -$77M -$79M -3950% Jun 30, 2015 10-K 2016-08-10
Q1 2015 -$62.3M -$81.1M -430% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 -$37M -$48.6M -419% Dec 31, 2014 10-Q 2015-02-04
Q3 2014 -$17.4M -$31.4M -225% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $2M -$28.9M -93.5% Jun 30, 2014 10-K 2015-08-12
Q1 2014 $18.9M +$16.8M +820% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $11.6M +$15.9M Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $14M +$29M Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $30.9M +$43.6M Jun 30, 2013 10-K 2014-08-13
Q1 2013 $2.05M +$2.14M Mar 31, 2013 10-Q 2013-05-08
Q4 2012 -$4.27M +$17.2M +80.1% Dec 31, 2012 10-Q 2013-02-06
Q3 2012 -$15M +$23.3M +60.8% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 -$12.7M +$25.9M +67.2% Jun 30, 2012 10-K 2013-08-14
Q1 2012 -$88K* +$48M +99.8% Mar 31, 2012 10-Q 2012-05-02
Q4 2011 -$21.4M -$769K -3.72% Dec 31, 2011 10-Q 2012-02-01
Q3 2011 -$38.3M -$34.5M -919% Sep 30, 2011 10-Q 2011-11-02
Q2 2011 -$38.6M -$28.2M -269% Jun 30, 2011 10-K 2012-08-15
Q1 2011 -$48.1M Mar 31, 2011 10-Q 2011-05-04
Q4 2010 -$20.7M Dec 31, 2010 10-Q 2011-02-01
Q3 2010 -$3.76M Sep 30, 2010 10-Q 2010-11-03
Q2 2010 -$10.5M Jun 30, 2010 10-K 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.